Practice question

Answer the question and get instant feedback.

Moderateadd GLP‑1 RA with proven CV benefit independent of A1C or metformin use to reduce MACE. DPP‑4 (A)Type 2 Diabetes Mellitus with ASCVDinsulin (e) lack comparable cv outcome benefits."

A 54-year-old man with T2D and ASCVD has BP 128/78 and A1C 7.2% on metformin. To reduce CV risk beyond glycemia, which addition is recommended independent of A1C?

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.